Addendum 2: Forum for Injection Technique, India

Indian Journal of Endocrinology and Metabolism

Volumn 18, Issue 6, 2014, Pages 800-803

  Kalra, Sanjay ^a   Balhara, Yatan Pal Singh ^b   Baruah, Manash P ^c   Chadha, Manoj ^d   Chandalia, Hemraj B ^e   Chowdhury, Subhankar ^f   Kesavadev, Jothydev ^g   Kumar, K M Prasanna ^h   Modi, Sonal ^e   Pitale, Shailesh ⁱ   Rishi, Shukla ^j   Sahay, Rakesh ^k   Sundaram, Annamalai ^l   Unnikrishnan, Ambika G ^m   Wangnoo, Subhash K ⁿ  

^a India   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c Endocrinology Unit   (India)

^d PD Hinduja Hospital and Research Centre   (India)

^e Diabetes Endocrine Nutrition Management and Research Centre   (India)

^f INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^g Jothydev's Diabetes and Research Center   (India)

^h M S RAMAIAH MEDICAL COLLEGE   (India)

ⁱ Pitale Diabetes and Hormone Center   (India)

^j Regency Hospital Ltd   (India)

^k OSMANIA MEDICAL COLLEGE   (India)

^l Kilpauk Medical College   (India)

^m AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

ⁿ INDRAPRASTHA APOLLO HOSPITAL   (India)

more..

Author keywords

Degludec; exenatide; exenatide LAR; Glucagon like peptide 1 receptor agonists; liraglutide

Indexed keywords

EID: 84995698656     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.141344     Document Type: Review

References (16)

1. Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab 2013;39:445-53.
2. Dische FE, Wernstedt C, Westermark GT, Westermark P, Pepys MB, Rennie JA, et al. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 1988;31:158-61.
3. Swift B. Examination of insulin injection sites: An unexpected finding of localized amyloidosis. Diabet Med 2002;19:881-2.
4. Albert SG, Obadiah J, Parseghian SA, Yadira Hurley M, Mooradian AD. Severe insulin resistance associated with subcutaneous amyloid deposition. Diabetes Res Clin Pract 2007;75:374-6.
5. Westermark P, Araki S, Benson MD, Cohen AS, Frangione B, Masters CL, et al. Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, Part. 1. Amyloid 1999;6:63-6.
6. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, et al. Amyloid fibril protein nomenclature. Amyloid 2002;9:197-200.
7. Dische FE, Wernstedt C, Westermark GT, Westermark P, Pepys MB, Rennie JA, et al. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 1988;31:158-61.
8. Swift B. Examination of insulin injection sites: An unexpected finding of localized amyloidosis. Diabet Med 2002;19:881-2.
9. Albert SG, Obadiah J, Parseghian SA, Yadira Hurley M, Mooradian AD. Severe insulin resistance associated with subcutaneous amyloid deposition. Diabetes Res Clin Pract 2007;75:374-6.
10. Shikama Y, Kitazawa J, Yagihashi N, Uehara O, Murata Y, Yajima N, et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med 2010;49:397-401.
11. American Diabetes Association. Insulin administration. Diabetes Care 2004;27:S106-9.
12. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al.; International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-9.
13. Brod M, Kongso JH, Lessard S, Christensen TL. Psychological insulin resistance: Patient beliefs and implication for diabetes management. Qual Life Res 2009;18:23-32.
14. Brod M, Kongso JH, Lessard S, Christensen TL. Psychological insulin resistance: Patient beliefs and implication for diabetes management. Qual Life Res 2009;18:23-32.
15. Bärtsch U, Comtesse C, Wetekam B. Injectable therapy pen devices for reatment of diabetes (article in German). Ther Umsch 2006;63:398-404.
16. Saez-de Ibarra L, Gallego F. Factors related to lypohypertrophy in insulin treated Diabetic Patients; role of educational intervention. Pract Diabetes Int 1998;5;9-11.